Subhash Banerjee MD, FACC, FSCAI

Subhash Banerjee, M.D., is a Professor in the UT Southwestern Department of Internal Medicine. He also serves as the Chief of Cardiology and Director of the Cardiac Catheterization Laboratory at the VA North Texas Health Care System in Dallas.

Dr. Banerjee earned his medical degree at Minsk Medical Institute and performed residencies in internal medicine at SJH/Batra Hospitals and New York Presbyterian Hospital. He then completed fellowships in cardiovascular diseases and interventional cardiology at the University of Iowa Hospitals and Clinics. He joined the UT Southwestern faculty in 2004.

Dr. Banerjee is the Director of the Cardiovascular Innovations annual scientific meeting, a section editor for the American College of Cardiology (ACC) Interventional Board Review, and a grant reviewer for the National Institutes of Health. He is also part of the VA Health Care System’s National Field Advisory Board for Cardiology, National Transcatheter Valve Therapy Committee, and Cath Lab Quality/Performance Improvement (CART-CL) Publication and Grants Committee.

Dr. Banerjee is a member of the American Heart Association, American College of Cardiology, and Society for Cardiovascular Angiography and Interventions. He is also a member of the UT Southwestern Cardiology Executive Council, the organizing committee of the ACC and Transcatheter Cardiovascular Therapeutics, the American Board of Internal Medicine interventional cardiology question-writing committee, and the ACC Peripheral Vascular Disease Council.

He is an editorial board member for leading medical journals, including the American Journal of Cardiology and the Journal of Endovascular Therapy. He is also a reviewer for several journals, including the Journal of the American College of Cardiology and Circulation.

Dr. Banerjee has been the recipient of grants from the American Heart Association, National Institutes of Health, and VA Cooperative Clinical Trial, as well as major industry grants. He is the principal investigator and founder of the Excellence in Peripheral Artery Disease (XLPAD) multicenter registry, and he holds medical device patents for a mobile health platform and a cardiovascular trapping sheath.